Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads to inherited childhood blindness. It also develops EDIT-102 for the treatment of Usher Syndrome 2A, which is a form of retinitis pigmentosa that also includes hearing loss; autosomal dominant retinitis pigmentosa, a progressive form of retinal degeneration; and EDIT-301 to treat sickle cell disease and transfusion-dependent beta-thalassemia. In addition, the company is developing gene-edited Natural Killer cell medicines to treat solid tumor cancers; alpha-beta T cells for multiple cancers; and gamma delta T cell therapies to treat cancer, as well as has an early discovery program to develop a therapy to treat a neurological disease. It has a research collaboration with Juno Therapeutics, Inc. to develop engineered T cells for cancer; strategic alliance and option agreement with Allergan Pharmaceuticals International Limited to discover, develop, and commercialize new gene editing medicines for a range of ocular disorders; and research collaboration with Asklepios BioPharmaceutical, Inc. to develop a therapy to treat a neurological disease, as well as research collaboration with AskBio. The company was formerly known as Gengine, Inc. and changed its name to Editas Medicine, Inc. in November 2013. Editas Medicine, Inc. was incorporated in 2013 and is based in Cambridge, Massachusetts.
$310.11M
Dr. Gilmore O'Neill
264.00
Cambridge, MA
Feb 03, 2016
-1.61
$-2.33
0.87
3.85
-288.59%
-1.66
-0.06
1.39
4.81
3.85
-50.27%
-62.61%
Similar stocks (9)
Vertex Pharmaceuticals Incorporated
VRTX
Intellia Therapeutics, Inc.
NTLA
Beam Therapeutics Inc.
BEAM
Sana Biotechnology, Inc.
SANA
Allogene Therapeutics, Inc.
ALLO
Prime Medicine, Inc.
PRME
Verve Therapeutics, Inc.
VERV
Ginkgo Bioworks Holdings, Inc.
DNA
Caribou Biosciences, Inc.
CRBU
ETF Exposure (50)
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.6%
Robo Global Healthcare Technology and Innovation ETF
HTEC
0.59%
Global X Genomics & Biotechnology ETF
GNOM
0.5%
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.358%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.32153%
Etho Climate Leadership U.S. ETF
ETHO
0.17%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.12%
SPDR S&P Biotech ETF
XBI
0.113392%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.0734569301%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.07%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.065525%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.03%
Vanguard Russell 2000 Value Index Fund
VTWV
0.03%
iShares Biotechnology ETF
IBB
0.02727%
iShares Russell 2000 Value ETF
IWN
0.02247%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
Dimensional U.S. Targeted Value ETF
DFAT
0.018527039999999998%
iShares Russell 2000 ETF
IWM
0.0114%
Schwab U.S. Small-Cap ETF
SCHA
0.0113248127%
Vanguard Small Cap Growth Index Fund
VBK
0.01%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Nasdaq Biotechnology
BIB
0.008278998476982316%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.008%
WisdomTree BioRevolution Fund
WDNA
0.006989%
Dimensional U.S. Small Cap ETF
DFAS
0.00611423%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.005918%
Fidelity MSCI Health Care Index ETF
FHLC
0.00492627%
ProShares Ultra Russell2000
UWM
0.004284357278463713%
ProShares UltraPro Russell2000
URTY
0.0021118186994496294%
ProShares Hedge Replication ETF
HDG
0.001791820906805638%
Schwab U.S. Broad Market ETF
SCHB
8.588179e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
7.7e-4%
Dimensional US Core Equity Market ETF
DFAU
6.902e-4%
Dimensional U.S. Equity ETF
DFUS
5.0561e-4%
iShares Russell 3000 ETF
IWV
4.6e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Small Cap Index Fund
NAESX
0%
Vanguard Small Cap Index Fund
VB
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Small-Cap Index Fund Institutional Shares
VSCIX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Similar stocks (9)
Vertex Pharmaceuticals Incorporated
VRTX
Intellia Therapeutics, Inc.
NTLA
Beam Therapeutics Inc.
BEAM
Sana Biotechnology, Inc.
SANA
Allogene Therapeutics, Inc.
ALLO
Prime Medicine, Inc.
PRME
Verve Therapeutics, Inc.
VERV
Ginkgo Bioworks Holdings, Inc.
DNA
Caribou Biosciences, Inc.
CRBU
ETF Exposure (50)
Listed Funds Trust - Horizon Kinetics Medical ETF
MEDX
0.6%
Robo Global Healthcare Technology and Innovation ETF
HTEC
0.59%
Global X Genomics & Biotechnology ETF
GNOM
0.5%
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.358%
iShares Genomics Immunology and Healthcare ETF
IDNA
0.32153%
Etho Climate Leadership U.S. ETF
ETHO
0.17%
Vanguard Strategic Small-Cap Equity Fund Investor Shares
VSTCX
0.12%
SPDR S&P Biotech ETF
XBI
0.113392%
Direxion Daily S&P Biotech Bull 3X Shares
LABU
0.0734569301%
Vanguard Horizon Funds - Vanguard Strategic Equity Fund
VSEQX
0.07%
SPDR S&P Kensho New Economies Composite ETF
KOMP
0.065525%
Invesco Nasdaq Biotechnology ETF
IBBQ
0.03%
Vanguard Russell 2000 Value Index Fund
VTWV
0.03%
iShares Biotechnology ETF
IBB
0.02727%
iShares Russell 2000 Value ETF
IWN
0.02247%
Vanguard Russell 2000 Index Fund
VTWO
0.02%
Dimensional U.S. Targeted Value ETF
DFAT
0.018527039999999998%
iShares Russell 2000 ETF
IWM
0.0114%
Schwab U.S. Small-Cap ETF
SCHA
0.0113248127%
Vanguard Small Cap Growth Index Fund
VBK
0.01%
Vanguard Health Care Index Fund
VHT
0.01%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0.01%
Vanguard Extended Market Index Fund
VXF
0.01%
ProShares Ultra Nasdaq Biotechnology
BIB
0.008278998476982316%
Invesco FTSE RAFI US 1500 Small-Mid ETF
PRFZ
0.008%
WisdomTree BioRevolution Fund
WDNA
0.006989%
Dimensional U.S. Small Cap ETF
DFAS
0.00611423%
SPDR Portfolio MSCI Global Stock Market ETF
SPGM
0.005918%
Fidelity MSCI Health Care Index ETF
FHLC
0.00492627%
ProShares Ultra Russell2000
UWM
0.004284357278463713%
ProShares UltraPro Russell2000
URTY
0.0021118186994496294%
ProShares Hedge Replication ETF
HDG
0.001791820906805638%
Schwab U.S. Broad Market ETF
SCHB
8.588179e-4%
iShares Core S&P Total U.S. Stock Market ETF
ITOT
7.7e-4%
Dimensional US Core Equity Market ETF
DFAU
6.902e-4%
Dimensional U.S. Equity ETF
DFUS
5.0561e-4%
iShares Russell 3000 ETF
IWV
4.6e-4%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Vanguard Small Cap Index Fund
NAESX
0%
Vanguard Small Cap Index Fund
VB
0%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Small-Cap Index Fund Institutional Shares
VSCIX
0%
Vanguard Russell 3000 Index Fund
VTHR
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%